James Ellingford

Dr James Ellingford has experience in the international arena and has successfully developed close ties with financial institutions and governments throughout the world.

Dr Ellingford holds a Post Graduate in Corporate Management, a Masters in Business Administration, and a Doctorate in Management.

Previously, he has chaired boards including MinRex Resources, Creso Pharma and Zyber Holdings (see data below).

Lists and Charts

Revenue

Rank	Company	#
481^st	Hyterra	$0
482^nd	Industrial Minerals	$0
483^rd	Ironbark Zinc	$0
484^th	Javelin Minerals	$0

600 public companies - resources WA ranked by total revenue

View Full List

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
820^th	InvestSMART Group	0%	0.79%
821^st	Magontec	0%	-19.73%
822^nd	Javelin Minerals	0%	0%
823^rd	Phoslock Environmental Technologies	0%	-51.11%
824^th	Medlab Clinical	0%	-34.5%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	NEWS: Tagged in Creso chair steps back following ASIC notice	25 Nov 2021
	REMUNERATION UPDATE: Executive Director, Interim Chair since 2021, Creso Pharma	03 Nov 2020
	REMUNERATION UPDATE: Non-Executive Chair, MinRex Resources	24 Aug 2020
	REMUNERATION UPDATE: Non-Executive Chair, MinRex Resources	30 Jun 2020

Article Timeline

Related Information

Positions - Previous

Position	Company	Year	Company's current rank
Executive Director, Interim Chair since 2021	Creso Pharma	2015 - 2022	37
Non-Executive Director	Roots Sustainable Agricultural Technologies	2020 - 2022	168
Non-Executive Chair	MinRex Resources	2017 - 2020	258
Non-Executive Chair	Javelin Minerals	2011 - 2019	484
Non-Executive Director	Paterson Resources	2017 - 2018	519
Non-Executive Chair	Dourado Resources	2014 - 2016
Non-Executive Chairman	Zyber Holdings	2014 - 2016
Non-Executive Director	Capital Mining	2013 - 2015
Non-Executive Director	Pursuit Minerals	-
Non-Executive Director	Pivotal Metals	-	386

Directors Interest

Company	Date	Transaction type	Number of shares	Price per share	Transaction value	Nature of change
Creso Pharma	2021-11-02	Issued	384,167	$0.00		Other
Creso Pharma	2021-07-14	Issued	500,000	$0.00		Other
Creso Pharma	2021-03-09	Other	797,500	$0.00		Other
Javelin Minerals	2018-11-30	Other	33,333	$0.00		Other
Creso Pharma	2018-08-21	Issued	550,000	$0.05	$27,500	Rights issue

Explore Full List

M&A Deals

Announced	Bidder	Target	Transaction Type	Total Value
02/09/15	Dourado Resources	Zyber Holdings	Reverse takeover	$2.60m	>>